Infigratinib for the Treatment of Metastatic or Locally Advanced Cholangiocarcinoma With Known FGFR2 Gene Fusions or Rearrangements

Cholangiocarcinoma (CCA) is an aggressive and diverse malignancy with a poor prognosis. Related to a typical indolent course of progression, most cases of CCA are metastatic or locally advanced at the time of presentation. For patients with nonresectable tumors or metastatic disease, the mainstay of...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Kathryn, Anwar, Ahmed I, Jin, Kevin, Bollich, Victoria, Kelkar, Rucha A, Talbot, Norris C, Klapper, Rachel J, Ahmadzadeh, Shahab, Viswanath, Omar, Varrassi, Giustino, Shekoohi, Sahar, Kaye, Alan D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634393/
https://www.ncbi.nlm.nih.gov/pubmed/37954763
http://dx.doi.org/10.7759/cureus.46792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634393/
https://www.ncbi.nlm.nih.gov/pubmed/37954763
http://dx.doi.org/10.7759/cureus.46792

Ejemplares similares